19 June 2013
Keywords: emergent, gets, hhs, nod, anthrax, vacc, contract
Article | 22 September 2008
US biopharmaceutical firm Emergent BioSolutions' proposal to provide recombinant protective antigen anthrax vaccine to the Department of
Health and Human ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 September 2008
29 September 2008
18 June 2013
© 2013 thepharmaletter.com